Sign in
8-K/A

Current Report

Larimar Therapeutics, Inc. Filed Acc 0001193125-20-257868

Executive or director change · Shareholder vote results

  • Item 5.02 Departure or appointment of directors or officers
  • Item 5.07 Submission of matters to a vote of security holders

From the SEC's structured data for this filing

Loading d887315d8ka.htm…